CNOT4
Basic information
Region (hg38): 7:135361795-135510145
Previous symbols: [ "NOT4" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CNOT4 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 14 | 14 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 14 | 0 | 0 |
Variants in CNOT4
This is a list of pathogenic ClinVar variants found in the CNOT4 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
7-135362923-T-G | not specified | Uncertain significance (Sep 11, 2024) | ||
7-135362941-G-T | not specified | Uncertain significance (Apr 19, 2024) | ||
7-135362964-G-T | not specified | Uncertain significance (Jul 09, 2021) | ||
7-135362988-G-A | not specified | Uncertain significance (Jan 27, 2022) | ||
7-135363022-C-T | not specified | Uncertain significance (Apr 05, 2023) | ||
7-135363082-C-G | not specified | Uncertain significance (Sep 20, 2023) | ||
7-135363153-G-C | not specified | Uncertain significance (Jun 12, 2023) | ||
7-135363905-T-C | not specified | Uncertain significance (Feb 10, 2022) | ||
7-135363934-G-A | not specified | Uncertain significance (Mar 30, 2024) | ||
7-135363965-A-C | not specified | Uncertain significance (Mar 30, 2024) | ||
7-135363985-T-C | not specified | Uncertain significance (Mar 30, 2024) | ||
7-135363991-T-G | not specified | Uncertain significance (Aug 07, 2024) | ||
7-135364034-T-C | not specified | Uncertain significance (Oct 12, 2024) | ||
7-135394025-C-G | not specified | Uncertain significance (Dec 01, 2022) | ||
7-135394076-C-T | not specified | Uncertain significance (Feb 28, 2024) | ||
7-135394131-A-T | not specified | Uncertain significance (Mar 30, 2024) | ||
7-135394137-A-G | not specified | Uncertain significance (Mar 30, 2024) | ||
7-135394170-C-T | not specified | Uncertain significance (May 20, 2024) | ||
7-135394212-T-C | not specified | Uncertain significance (Oct 19, 2024) | ||
7-135394221-G-A | not specified | Uncertain significance (Jul 02, 2024) | ||
7-135394239-G-C | not specified | Uncertain significance (Feb 02, 2024) | ||
7-135394242-A-G | not specified | Uncertain significance (Apr 20, 2024) | ||
7-135394260-G-C | not specified | Uncertain significance (Jul 13, 2021) | ||
7-135395772-T-C | not specified | Uncertain significance (Apr 26, 2024) | ||
7-135395795-C-T | not specified | Uncertain significance (Jan 23, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CNOT4 | protein_coding | protein_coding | ENST00000541284 | 11 | 148329 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 0.0000395 | 114657 | 0 | 1 | 114658 | 0.00000436 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 3.49 | 207 | 405 | 0.512 | 0.0000217 | 4688 |
Missense in Polyphen | 45 | 153.58 | 0.293 | 1801 | ||
Synonymous | 0.348 | 147 | 152 | 0.964 | 0.00000867 | 1394 |
Loss of Function | 5.17 | 1 | 33.1 | 0.0302 | 0.00000181 | 364 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00000945 | 0.00000945 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Has E3 ubiquitin ligase activity, promoting ubiquitination and degradation of target proteins (PubMed:11823428, PubMed:22159038, PubMed:26575292). Involved in activation of the JAK/STAT pathway (PubMed:11823428, PubMed:22159038). Catalyzes ubiquitination of methylated RBM15 (PubMed:26575292). {ECO:0000269|PubMed:11823428, ECO:0000269|PubMed:22159038, ECO:0000269|PubMed:26575292}.;
- Pathway
- RNA degradation - Homo sapiens (human);Gene expression (Transcription);Generic Transcription Pathway;RNA Polymerase II Transcription;Metabolism of RNA;TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain;TP53 Regulates Transcription of Cell Cycle Genes;Transcriptional Regulation by TP53;Deadenylation of mRNA;Deadenylation-dependent mRNA decay
(Consensus)
Recessive Scores
- pRec
- 0.133
Intolerance Scores
- loftool
- 0.120
- rvis_EVS
- 0.04
- rvis_percentile_EVS
- 57.31
Haploinsufficiency Scores
- pHI
- 0.638
- hipred
- Y
- hipred_score
- 0.843
- ghis
- 0.576
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- K
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.912
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Cnot4
- Phenotype
- hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); immune system phenotype; skeleton phenotype; limbs/digits/tail phenotype;
Gene ontology
- Biological process
- nuclear-transcribed mRNA poly(A) tail shortening;ubiquitin-dependent protein catabolic process;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;protein ubiquitination;regulation of megakaryocyte differentiation;protein autoubiquitination
- Cellular component
- nucleus;cytosol;CCR4-NOT complex
- Molecular function
- RNA binding;ubiquitin-protein transferase activity;protein binding;metal ion binding